Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of the fixed-dose combination ledipasvir/sofosbuvir with or without ribavirin in treatment-experienced genotype 1 he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/Sofosbuvir + Ribavirin (ledipasvir/sofosbuvir with ribavirin)
• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis C Virus | Phase 3 | Status: COMPLETED | Results posted: 2014-11-26